These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30069601)

  • 1. Galectin-3 as a novel biomarker in women with PCOS.
    Anik Ilhan G; Kanlioglu C; Arslan G; Yildizhan B; Pekin T
    Arch Gynecol Obstet; 2018 Oct; 298(4):821-825. PubMed ID: 30069601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotrophin-1 as a new metabolic biomarker in women with PCOS.
    Anik Ilhan G; Kanlioglu C; Arslan G; Yildizhan B; Pekin T
    Gynecol Endocrinol; 2018 Sep; 34(9):781-783. PubMed ID: 29600728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum galectin-3 levels in women with PCOS.
    Yilmaz H; Celik HT; Ozdemir O; Kalkan D; Namuslu M; Abusoglu S; Atalay CR; Yigitoglu R
    J Endocrinol Invest; 2014 Feb; 37(2):181-7. PubMed ID: 24497217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Anik Ilhan G; Yildizhan B; Pekin T
    Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sex hormone-binding globulin on predicting metabolic syndrome in newly diagnosed and untreated patients with polycystic ovary syndrome.
    Fu C; Minjie C; Weichun Z; Huihuang Y; Guishan C; Qingxia H; Xiaoping Y; Lan C; Ping W; Chujia L; Guoshu Y
    Hormones (Athens); 2020 Sep; 19(3):439-445. PubMed ID: 32562143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C, a novel cardiometabolic risk marker in women with polycystic ovary syndrome.
    Yildirim A; Yildizhan B; Anik Ilhan G; Pekin T
    Gynecol Endocrinol; 2016 Jun; 32(6):457-9. PubMed ID: 26758793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of metabolic syndrome in women with polycystic ovary syndrome.
    Ersan F; Arslan E; Esmer AÇ; Aydın S; Gedikbaşı A; Gedikbaşı A; Alkış I; Ark C
    J Turk Ger Gynecol Assoc; 2012; 13(3):178-83. PubMed ID: 24592034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
    Gupta V; Mishra S; Mishra S; Gupta V
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome?
    Behboudi-Gandevani S; Ramezani Tehrani F; Cheraghi L; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():110-4. PubMed ID: 27579518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome.
    Marchesan LB; Spritzer PM
    Fertil Steril; 2019 Mar; 111(3):579-587.e1. PubMed ID: 30827526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
    Torun AN; Vural M; Cece H; Camuzcuoglu H; Toy H; Aksoy N
    Gynecol Endocrinol; 2011 Dec; 27(12):988-92. PubMed ID: 21557696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.
    Sahin FK; Sahin SB; Ural UM; Cure MC; Senturk S; Tekin YB; Balik G; Cure E; Yuce S; Kirbas A
    Bosn J Basic Med Sci; 2015 Jul; 15(3):57-63. PubMed ID: 26295295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women.
    Boyle JA; Cunningham J; Norman RJ; Dunbar T; O'Dea K
    Intern Med J; 2015 Dec; 45(12):1247-54. PubMed ID: 26387977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.